ALS Worldwide welcomes any questions or comments you might have.  We provide free, personalized and confidential support services to anyone in the ALS community—whether you are a patient or a loved one, friend, health care professional or caregiver of someone diagnosed.

Get help now! Fill out the Online Profile Form or if you would prefer to talk with someone by email or phone first, please contact us at [email protected] or 1-608-663-0920.

For all other inquiries, please use the email form to the right and we will respond promptly to your request.Thank you.

ALS Worldwide
5808 Dawley Drive
Fitchburg, WI 53711‑7209

ALS Worldwide
Sorted by category: MicroNeurotrophins | View All
February 22, 2016

MicroNeurotrophins: An Introduction

A brief overview of MicroNeurotrophins, a set of promising drugs to treat ALS/MND and other neurodegenerative diseases.

February 16, 2016

MicroNeurotrophin Drug Development: Key Steps

A summary of the completed steps and those that still need funding in the MicroNeurotrophin development process

February 16, 2016

MicroNeurotrophin Research: ALS Worldwide’s Scientific Partners

Biographies of each of the renowned neuroscientists that led the preclinical research on MicroNeurotrophin drugs.

February 16, 2016

Preclinical Trial Results: MicroNeurotrophins

After rigorous pre-clinical testing, MicroNeurotrophin drugs show no signs of toxicity or harmful side effects and appear to protect and strengthen the nerve cells affected by ALS.